A Novel Particulate Form of Ca(2+)/calmodulin-dependent [correction of Ca(2+)/CaMKII-dependent] Protein Kinase II in Neurons
Overview
Authors
Affiliations
Cytoskeletal and postsynaptic density (PSD) fractions from forebrain contain discrete spherical structures that are immunopositive for Ca(2+)/calmodulin-dependent protein kinase II (CaMKII). Spherical structures viewed by rotary shadow electron microscopy have an average diameter of approximately 100 nm and, in distinction to postsynaptic densities, do not immunolabel for PSD-95. These structures were purified to near homogeneity by extraction with the detergent N-lauryl sarcosinate. Biochemical analysis revealed that CaMKII accounts for virtually all of the protein in the purified preparation, suggesting that spherical structures are clusters of self-associated CaMKII. Exposure of cultured hippocampal neurons to a mitochondrial uncoupler in glucose-free medium promotes the formation of numerous CaMKII-immunopositive structures identical in size and shape to the CaMKII clusters observed in subcellular fractions. Clustering of CaMKII would reduce its kinase function by preventing its access to fixed substrates. On the other hand, clustering would not affect the ability of the large cellular pool of CaMKII to act as a calmodulin sink, as demonstrated by the Ca(2+)-dependent binding of gold-conjugated calmodulin to CaMKII clusters. We propose that the observed clustering of CaMKII into spherical structures is a protective mechanism preventing excessive protein phosphorylation upon loss of Ca(2+) homeostasis, without compromising calmodulin regulation.
Bolton S, Thompson D, Kinzer-Ursem T PLoS One. 2024; 19(1):e0285651.
PMID: 38180986 PMC: 10769071. DOI: 10.1371/journal.pone.0285651.
Nicoll R, Schulman H Physiol Rev. 2023; 103(4):2877-2925.
PMID: 37290118 PMC: 10642921. DOI: 10.1152/physrev.00034.2022.
CaMKIIα as a Promising Drug Target for Ischemic Grey Matter.
Griem-Krey N, Clarkson A, Wellendorph P Brain Sci. 2022; 12(12).
PMID: 36552099 PMC: 9775128. DOI: 10.3390/brainsci12121639.
Buonarati O, Miller A, Coultrap S, Bayer K, Reichow S Cell Rep. 2021; 37(13):110168.
PMID: 34965414 PMC: 8985225. DOI: 10.1016/j.celrep.2021.110168.
Tao-Cheng J, Crocker V, Moreira S, Azzam R Mol Brain. 2021; 14(1):86.
PMID: 34082785 PMC: 8173732. DOI: 10.1186/s13041-021-00799-2.